NEW YORK (Reuters Health) – Compared with a strategy of optimal medical therapy alone for treatment of stable coronary artery disease (CAD), the addition of percutaneous coronary intervention…
NEW YORK (Reuters Health) – Intracoronary nicardipine before elective percutaneous coronary intervention (PCI) does not reduce post-treatment cardiac enzyme leakage in low-risk patients, new research shows. Prior research…
NEW YORK (Reuters Health) – In patients with ST-segment elevation myocardial infarction (STEMI), substantial myocardial salvage and reduced infarct size can be achieved even when primary angioplasty is…
NEW YORK (Reuters Health) – In patients with atherosclerotic renal artery stenosis (ARAS) and impaired renal function who are receiving aggressive medical therapy, renal artery stenting offers little…
NEW YORK (Reuters Health) – The results of a study at the German Heart Center in Munich suggest that transcatheter aortic valve implantation can lead to clinically relevant…
NEW YORK (Reuters Health) – A body mass index that falls outside the normal range is associated with an increased risk of bleeding and death after percutaneous coronary…
NEW YORK (Reuters Health) – In the real-world setting of contemporary clinical cardiology practices, adverse events following percutaneous cardiovascular procedures are substantially reduced by using radial artery access…
NEW YORK (Reuters Health) – A fibrin-derived peptide (FX06) appears to limit infarct size when given during percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction, according…
DMC pediatric heart specialist uses less invasive technique to repair a child’s Atrial Septal Defect (“hole in the heart”). For more information, please see: Dan Turner, M.D. Sponsored…
NEW YORK (Reuters Health) – Manual thrombus aspiration during primary percutaneous coronary intervention (PCI) improves myocardial reperfusion and reduces final infarct size in patients with ST-segment elevation myocardial…